Can Single Positive Core Prostate Cancer at biopsy be Considered a Low-Risk Disease after Radical Prostatectomy?
Author:
Affiliation:
1. University of Sao Paulo Medical School, Brazil
Publisher
FapUNIFESP (SciELO)
Subject
Urology
Link
http://www.scielo.br/pdf/ibju/v39n6/1677-5538-ibju-39-06-800.pdf
Reference30 articles.
1. Cancer treatment and survivorship statistics, 2012;Siegel R;CA Cancer J Clin,2012
2. Role of repeated biopsy of the prostate in predicting disease progression in patients with prostate cancer on activesurveillance;Al Otaibi M;Cancer,2008
3. Prostate-cancer mortality at 11 years of follow-up;Schröder FH;N Engl J Med,2012
4. Can a Gleason 6 or Less Microfocus of Prostate Cancer in One Biopsy and Prostate-Specific Antigen Level <10 ng/mL Be Defined as the Archetype of Low-Risk Prostate Disease?;Taverna G;J Oncol,2012
5. Single positive core prostate cancer in a 12-core transrectal biopsy scheme: clinicopathological implications compared withmultifocal counterpart;Ahn HJ;Korean J Urol,2010
Cited by 9 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Treatment patterns and rates of upgrading and upstaging in prostate cancer patients with single GGG1 positive biopsy core;Urologic Oncology: Seminars and Original Investigations;2022-09
2. Up- and downgrading in single intermediate-risk positive biopsy core prostate cancer;Prostate International;2022-03
3. Single Positive Core Prostate Cancer at Biopsy: Clinicopathological Implications and Risk Factors for Adverse Pathological Outcomes;Clinical Genitourinary Cancer;2021-12
4. Analysis of risk factors for Gleason score upgrading after radical prostatectomy in a Chinese cohort;Cancer Medicine;2021-09-16
5. Discovery of A031 as effective proteolysis targeting chimera (PROTAC) androgen receptor (AR) degrader for the treatment of prostate cancer;European Journal of Medicinal Chemistry;2021-04
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3